Ascend Wellness Holdings, Inc. SEC filings AAWH
Ascend Wellness Holdings, Inc. has 147 filings in SEC EDGAR's recent list, going back to Oct 24, 2018. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 31, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Aug 31, 2026 | Aug 28, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| DEFA14A | Additional proxy material | Aug 10, 2026 | — |
| DEFA14A | Additional proxy material | Jul 10, 2026 | — |
| DEF 14A | Proxy statement | Jul 9, 2026 | Aug 28, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 29, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 25, 2026 | Jun 24, 2026 |
| PREM14A | Filing | Jun 25, 2026 | Aug 28, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
May 5, 2026 | Apr 29, 2026 |
| ARS | Annual report to shareholders | Mar 20, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 20, 2026 | — |
| DEF 14A | Proxy statement | Mar 20, 2026 | Apr 29, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Other events
|
Feb 13, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Other events
|
Feb 6, 2026 | Feb 5, 2026 |
| EFFECT | Filing | Jan 22, 2026 | — |
| CORRESP | Letter to the SEC | Jan 20, 2026 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2025 | — |
| S-3 | Shelf registration | Dec 19, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| D | Filing | Jun 11, 2025 | — |
| 8-K |
Current report
New debt, Other events
|
May 28, 2025 | May 28, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 2, 2025 | Apr 30, 2025 |
| ARS | Annual report to shareholders | Mar 21, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 21, 2025 | — |
| DEF 14A | Proxy statement | Mar 21, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Auditor change
|
Mar 21, 2025 | Mar 19, 2025 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2025 | Mar 12, 2025 |
| D | Filing | Jan 23, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Jan 14, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Other events
|
Dec 27, 2024 | Dec 27, 2024 |
| 8-K |
Current report
Other events
|
Dec 17, 2024 | Dec 17, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 28, 2024 | Aug 26, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Jul 22, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Other events
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 31, 2024 | May 31, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Shareholder vote results
|
May 7, 2024 | May 3, 2024 |
| ARS | Annual report to shareholders | Apr 2, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 2, 2024 | May 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Mar 26, 2024 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2024 | Mar 12, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Oct 25, 2023 | Oct 25, 2023 |
| EFFECT | Filing | Aug 25, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2023 | — |
| CORRESP | Letter to the SEC | Aug 24, 2023 | — |
| S-3 | Shelf registration | Aug 22, 2023 | — |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| S-8 | Employee stock plan registration | Aug 8, 2023 | — |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| D | Filing | Jul 7, 2023 | — |
| 8-K |
Current report
Unregistered share sale
|
Jun 16, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Other events
|
Jun 15, 2023 | Jun 14, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change, Shareholder vote results
|
May 9, 2023 | May 5, 2023 |
| 8-K |
Current report
Unregistered share sale
|
May 2, 2023 | Apr 27, 2023 |
| ARS | Annual report to shareholders | Mar 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 24, 2023 | — |
| DEF 14A | Proxy statement | Mar 24, 2023 | May 5, 2023 |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2023 | Mar 14, 2023 |
| EFFECT | Filing | Dec 22, 2022 | — |
| CORRESP | Letter to the SEC | Dec 20, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Nov 23, 2022 | Nov 21, 2022 |
| S-3 | Shelf registration | Nov 22, 2022 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Other events
|
Oct 4, 2022 | Oct 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2022 | Sep 27, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 15, 2022 | Sep 14, 2022 |
| 8-K |
Current report
Other events
|
Aug 16, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| D | Filing | Jul 25, 2022 | — |
| 8-K |
Current report
New debt, Unregistered share sale
|
Jul 5, 2022 | Jun 30, 2022 |
| 8-K |
Current report
New debt
|
May 24, 2022 | May 18, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Other events
|
May 11, 2022 | May 10, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 11, 2022 | May 6, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| D | Filing | Apr 27, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 25, 2022 | Apr 19, 2022 |
| DEFA14A | Additional proxy material | Mar 28, 2022 | — |
| DEF 14A | Proxy statement | Mar 28, 2022 | May 6, 2022 |
| 10-K | Annual report | Mar 11, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2022 | Mar 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 16, 2022 | Feb 11, 2022 |
| 8-K |
Current report
Other events
|
Jan 6, 2022 | Jan 6, 2022 |
| 8-K |
Current report
Other events
|
Jan 4, 2022 | Jan 3, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Auditor change
|
Oct 1, 2021 | Sep 28, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Sep 1, 2021 | Aug 27, 2021 |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| S-8 | Employee stock plan registration | Jul 9, 2021 | — |
| 10-Q | Quarterly report | May 26, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 18, 2021 | May 18, 2021 |
| 424B4 | Prospectus | Apr 29, 2021 | — |
| EFFECT | Filing | Apr 28, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 28, 2021 | — |
| CORRESP | Letter to the SEC | Apr 27, 2021 | — |
| S-1/A | Amended registration statement | Apr 26, 2021 | — |
| S-1/A | Amended registration statement | Apr 23, 2021 | — |
| CORRESP | Letter to the SEC | Apr 22, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2021 | — |
| CORRESP | Letter to the SEC | Apr 15, 2021 | — |
| S-1/A | Amended registration statement | Apr 15, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 5, 2021 | — |
| S-1 | Registration statement | Mar 29, 2021 | — |
| CORRESP | Letter to the SEC | Mar 26, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2021 | — |
| DRS/A | Filing | Feb 26, 2021 | — |
| DRSLTR | Filing | Feb 25, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2021 | — |
| D | Filing | Jan 21, 2021 | — |
| DRS | Filing | Dec 28, 2020 | — |
| D | Filing | Jun 25, 2019 | — |
| D | Filing | Mar 11, 2019 | — |
| D | Filing | Oct 24, 2018 | — |
Showing 140 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- AAWH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochelle Park, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1756390
- Former names
- Ascend Wellness Holdings, Inc (until Mar 11, 2022); Ascend Wellness Holdings, LLC (until Apr 15, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.